Ramael S

Title : Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers - Bergman_2006_Clin.Ther_28_55

Author(s) : Bergman AJ , Stevens C , Zhou Y , Yi B , Laethem M , De Smet M , Snyder K , Hilliard D , Tanaka W , Zeng W , Tanen M , Wang AQ , Chen L , Winchell G , Davies MJ , Ramael S , Wagner JA , Herman GA

Ref : Clin Ther , 28 :55 , 2006

Abstract :

PubMedSearch : Bergman_2006_Clin.Ther_28_55

PubMedID: 16490580

Title : First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide - Gijsenbergh_2005_Anesthesiology_103_695

Author(s) : Gijsenbergh F , Ramael S , Houwing N , van Iersel T

Ref : Anesthesiology , 103 :695 , 2005

Abstract :

PubMedSearch : Gijsenbergh_2005_Anesthesiology_103_695

PubMedID: 16192761

Ramael S

References (2)

1. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers - Bergman_2006_Clin.Ther_28_55

2. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide - Gijsenbergh_2005_Anesthesiology_103_695